Chickasaw Capital Management’s Pfizer PFE Stock Holding History

Chickasaw Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,460	Closed	-$216K	–	100
2024 Q3	$216K	Hold	7,460	–	–	0.01%	94
2024 Q2	$209K	Hold	7,460	–	–	0.01%	92
2024 Q1	$207K	Hold	7,460	–	–	0.01%	94
2023 Q4	$215K	Sell	7,460 -8,180	-52%	-$247K	0.01%	86
2023 Q3	$519K	Hold	15,640	–	–	0.03%	59
2023 Q2	$574K	Hold	15,640	–	–	0.03%	60
2023 Q1	$638K	Hold	15,640	–	–	0.03%	60
2022 Q4	$801K	Sell	15,640 -645	-4%	-$30.9K	0.04%	56
2022 Q3	$713K	Hold	16,285	–	–	0.04%	55
2022 Q2	$854K	Hold	16,285	–	–	0.04%	54
2022 Q1	$843K	Sell	16,285 -200	-1%	-$10.4K	0.04%	56
2021 Q4	$973K	Sell	16,485 -1,300	-7%	-$64.4K	0.05%	54
2021 Q3	$765K	Hold	17,785	–	–	0.04%	57
2021 Q2	$696K	Buy	17,785 +5,145	+41%	+$200K	0.03%	59
2021 Q1	$458K	Sell	12,640 -135	-1%	-$4.79K	0.02%	65
2020 Q4	$470K	Buy	12,775 +2,051	+19%	+$75.2K	0.03%	63
2020 Q3	$373K	Buy	+10,724	New	+$376K	0.03%	60
2020 Q1	–	Sell	-5,981	Closed	-$222K	–	82
2019 Q4	$222K	Hold	5,981	–	–	0.01%	83
2019 Q3	$204K	Hold	5,981	–	–	0.01%	81
2019 Q2	$246K	Hold	5,981	–	–	0.01%	74
2019 Q1	$241K	Hold	5,981	–	–	0.01%	75
2018 Q4	$248K	Sell	5,981 -6,324	-51%	-$263K	0.01%	76
2018 Q3	$515K	Hold	12,305	–	–	0.01%	78
2018 Q2	$424K	Buy	12,305 +5,270	+75%	+$180K	0.01%	81
2018 Q1	$237K	Hold	7,035	–	–	0.01%	96
2017 Q4	$242K	Hold	7,035	–	–	0.01%	94
2017 Q3	$238K	Hold	7,035	–	–	0.01%	93
2017 Q2	$224K	Hold	7,035	–	–	﹤0.01%	94
2017 Q1	$228K	Sell	7,035 -53	-0.7%	-$1.67K	﹤0.01%	92
2016 Q4	$218K	Buy	7,088 +53	+0.8%	+$1.62K	﹤0.01%	89
2016 Q3	$226K	Hold	7,035	–	–	0.01%	84
2016 Q2	$235K	Buy	+7,035	New	+$225K	0.01%	87
2016 Q1	–	Sell	-7,035	Closed	-$215K	–	100
2015 Q4	$215K	Hold	7,035	–	–	0.01%	90
2015 Q3	$210K	Hold	7,035	–	–	0.01%	91
2015 Q2	$224K	Hold	7,035	–	–	0.01%	93
2015 Q1	$232K	Hold	7,035	–	–	0.01%	91
2014 Q4	$208K	Buy	+7,035	New	+$202K	0.01%	97
2014 Q2	–	Sell	-7,035	Closed	-$214K	–	107
2014 Q1	$214K	Buy	+7,035	New	+$210K	0.01%	97

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chickasaw Capital Management's PFE Position: Q4 2024 in Review

Chickasaw Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,460 shares — an estimated $216K sold.

Chickasaw Capital Management first reported a position in PFE in Q1 2014 and held it in 38 quarters. The position peaked at $973K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Chickasaw Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Chickasaw Capital Management sold 7,460 Pfizer shares in Q4 2024, an estimated $216K.
Chickasaw Capital Management first reported a position in Pfizer in Q1 2014 and held it in 38 quarters.
Chickasaw Capital Management's Pfizer position peaked at $973K in Q4 2021.
2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Chickasaw Capital Management's 13F filing for Q4 2024, filed 7 Jan 2025.